| Stage | CME | % of rev | ICE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $2.8B | 100.00% | ICE ×1.59 |
| Gross profit | $1.5B | 86.51% | $2.8B | 100.00% | ICE +13.5pp |
| Operating income | $1.1B | 65.70% | $1.4B | 50.99% | CME +14.7pp |
| Pre-tax income | $1.4B | 77.98% | $1.2B | 44.92% | CME +33.1pp |
| Net income | $1.0B | 59.68% | $956M | 34.58% | CME +25.1pp |
| Stage | CME | ICE | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $2.8B100.00% | ICE ×1.59 |
| Gross profit | 86.51%$1.5B | 100.00%$2.8B | ICE +13.5pp |
| Operating income | 65.70%$1.1B | 50.99%$1.4B | CME +14.7pp |
| Pre-tax income | 77.98%$1.4B | 44.92%$1.2B | CME +33.1pp |
| Net income |
| 59.68%$1.0B |
| 34.58%$956M |
| CME +25.1pp |